S-cubed Pharmaceutical Services ApS: Financial statements 2022
CVR: 39035448
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
S-cubed Pharmaceutical Services ApS (CVR 39035448) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 236,509 and a net result of DKK 174,554 compared with DKK 323,139 the year before. That is a decrease of 40.4% compared with the year before. Equity in the 2022 report amounted to DKK 647,396. The solvency ratio was 91.7%.
- Gross Profit
- DKK 236,509
- Profit/Loss
- DKK 174,554
- Equity
- DKK 647,396
- Total Assets
- DKK 706,326
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 237K | 175K | 647K | - |
| 2021 | - | 397K | 323K | 473K | 1 |
| 2020 | - | 146K | 142K | 150K | 1 |
| 2019 | - | 475K | -207K | 7K | 1 |
Official annual report
Keep an eye on S-cubed Pharmaceutical Services ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
S-cubed Pharmaceutical Services ApS has published its annual report for 2021. Gross profit came to DKK 396,638, and the net result was DKK 323,139.
About S-cubed Pharmaceutical Services ApS
S-cubed Pharmaceutical Services ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mark Dennis Lipscombe. The company is owned by S-Cubed Limited. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,235 and a net result of DKK -959 compared with DKK -51,181 the year before. Equity in the 2025 report amounted to DKK 599,313.